{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:51:27Z","timestamp":1792097487899,"version":"4.4.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01ES015991"],"award-info":[{"award-number":["R01ES015991"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01ES021800"],"award-info":[{"award-number":["R01ES021800"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01ES026057"],"award-info":[{"award-number":["R01ES026057"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM104037"],"award-info":[{"award-number":["R01GM104037"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30ES005022"],"award-info":[{"award-number":["P30ES005022"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01NS079249"],"award-info":[{"award-number":["U01NS079249"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32007148"],"award-info":[{"award-number":["T32007148"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21ES013828"],"award-info":[{"award-number":["R21ES013828"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.neuropharm.2017.07.020","type":"journal-article","created":{"date-parts":[[2017,7,23]],"date-time":"2017-07-23T01:01:10Z","timestamp":1500771670000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1"],"prefix":"10.1016","volume":"125","author":[{"given":"Ashley L.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseel","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Zarbl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6521-610X","authenticated-orcid":false,"given":"Jason R.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.07.020_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bcpt.12201","article-title":"Induction of neurotrophic and differentiation factors in neural stem cells by valproic acid","volume":"115","author":"Almutawaa","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0306-4522(99)00124-4","article-title":"Differential expression of tyrosine hydroxylase in catecholaminergic neurons of neonatal wild-type and Nurr1-deficient mice","volume":"93","author":"Baffi","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2015.06.018","article-title":"Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line","volume":"99","author":"Balasubramanian","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nbt.1759","article-title":"Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes","volume":"29","author":"Bantscheff","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00702-011-0688-4","article-title":"Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells","volume":"119","author":"Bence","year":"2012","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686117","article-title":"Distribution of histone deacetylases 1-11 in the rat brain","volume":"31","author":"Broide","year":"2007","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2014.02.028","article-title":"Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease","volume":"267","author":"Carriere","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.npp.1300023","article-title":"Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia","volume":"28","author":"Casey","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng.2007.58","article-title":"Epigenetic regulation and the variability of gene expression","volume":"40","author":"Choi","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.mcn.2004.09.008","article-title":"The homeodomain transcription factor Pitx3 facilitates differentiation of mouse embryonic stem cells into AHD2-expressing dopaminergic neurons","volume":"28","author":"Chung","year":"2005","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1073\/pnas.95.3.1265","article-title":"Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells","volume":"95","author":"Clarkson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt 8","key":"10.1016\/j.neuropharm.2017.07.020_bib12","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","article-title":"Histone deacetylase inhibitors: overview and perspectives","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000204229","article-title":"Nurr1 expression and its modulation in microglia","volume":"16","author":"Fan","year":"2009","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuropharm.2012.06.043","article-title":"Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity","volume":"64","author":"Fass","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.tips.2010.09.003","article-title":"Targeting the correct HDAC(s) to treat cognitive disorders","volume":"31","author":"Fischer","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0165-6147(93)90029-J","article-title":"Molecular characterization of the dopamine transporter","volume":"14","author":"Giros","year":"1993","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib18","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib19","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s11064-015-1601-6","article-title":"Epigenetic regulation of dopamine transporter mRNA expression in human neuroblastoma cells","volume":"40","author":"Green","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cell.2007.01.030","article-title":"Chromatin challenges during DNA replication and repair","volume":"128","author":"Groth","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib22","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/stem.739","article-title":"Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications","volume":"29","author":"He","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/toxsci\/kfr111","article-title":"Mechanism of pyrethroid pesticide-induced apoptosis: role of calpain and the ER stress pathway","volume":"122","author":"Hossain","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia: version III\u2013the final common pathway","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-328X(03)00162-1","article-title":"Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice","volume":"114","author":"Hwang","year":"2003","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1471-4159.2009.06404.x","article-title":"Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons","volume":"111","author":"Hwang","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1242\/dev.029769","article-title":"Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression","volume":"136","author":"Jacobs","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pneurobio.2005.09.001","article-title":"The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease","volume":"77","author":"Jankovic","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuroscience.2011.08.010","article-title":"Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"194","author":"Kidd","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib30","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1006\/bbrc.1997.7754","article-title":"Intronic sequences are involved in neural targeting of human dopamine transporter gene expression","volume":"240","author":"Kouzmenko","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib31","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/stem.294","article-title":"Foxa2 and Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved differentiation, function, and cell survival","volume":"28","author":"Lee","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib68","doi-asserted-by":"crossref","first-page":"9277","DOI":"10.1523\/JNEUROSCI.3021-08.2008","article-title":"Identification of a novel Nurr1 interacting protein","volume":"28","author":"Luo","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(02)01711-9","article-title":"DNA hypomethylating agents 5-aza-2'-deoxycytidine and valproate increase neuronal 5-lipoxygenase mRNA","volume":"445","author":"Manev","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib34","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1471-4159.2009.06385.x","article-title":"Valproic acid induces functional heat-shock protein 70 via class I histone deacetylase inhibition in cortical neurons: a potential role of Sp1 acetylation","volume":"111","author":"Marinova","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib36","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1073\/pnas.0511153103","article-title":"Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype","volume":"103","author":"Martinat","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/1874467210902010095","article-title":"Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection","volume":"2","author":"Monti","year":"2009","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijdevneu.2013.02.005","article-title":"Unique functional roles for class I and class II histone deacetylases in central nervous system development and function","volume":"31","author":"Morris","year":"2013","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib39","first-page":"169","article-title":"Differential regulation of transcription by the NURR1\/NUR77 subfamily of nuclear transcription factors","volume":"5","author":"Murphy","year":"1996","journal-title":"Gene Expr."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.tips.2009.07.002","article-title":"Sodium valproate: an old drug with new roles","volume":"30","author":"Nalivaeva","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2010.10.002","article-title":"Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction?","volume":"20","author":"Novy","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1196\/annals.1417.003","article-title":"Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice","volume":"1129","author":"Palmiter","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib43","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/npp.2009.188","article-title":"Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes","volume":"35","author":"Perisic","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2710.2005.00671.x","article-title":"Valproate: a simple chemical with so much to offer","volume":"30","author":"Peterson","year":"2005","journal-title":"J.\u00a0Clin. Pharm. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib45","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/BF02631258","article-title":"Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue","volume":"30A","author":"Prasad","year":"1994","journal-title":"In\u00a0Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib46","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0006-3223(02)01489-0","article-title":"Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system","volume":"53","author":"Ralph-Williams","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.devbrainres.2003.09.010","article-title":"Making connections: the development of mesencephalic dopaminergic neurons","volume":"147","author":"Riddle","year":"2003","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib48","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2174\/092986706776360905","article-title":"Chemistry and biology of chromatin remodeling agents: state of art and future perspectives of HDAC inhibitors","volume":"13","author":"Rodriquez","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib49","doi-asserted-by":"crossref","first-page":"e100343","DOI":"10.1371\/journal.pone.0100343","article-title":"Differential acetylation of histone H3 at the regulatory region of OsDREB1b promoter facilitates chromatin remodelling and transcription activation during cold stress","volume":"9","author":"Roy","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0169-328X(99)00275-2","article-title":"Characterization of the 5'-flanking region of the human dopamine transporter gene","volume":"74","author":"Sacchetti","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib51","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1046\/j.1471-4159.2001.00181.x","article-title":"Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism","volume":"76","author":"Sacchetti","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2009.01.038","article-title":"A\u00a0Nurr1\/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death","volume":"137","author":"Saijo","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1146\/annurev.biochem.76.052705.162114","article-title":"Functions of site-specific histone acetylation and deacetylation","volume":"76","author":"Shahbazian","year":"2007","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib54","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1242\/dev.01022","article-title":"Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3","volume":"131","author":"Smidt","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib55","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1046\/j.1460-9568.2003.02885.x","article-title":"Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons","volume":"18","author":"Smits","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-3-211-45295-0_10","article-title":"The role of Pitx3 in survival of midbrain dopaminergic neurons","author":"Smits","year":"2006","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib57","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"Tremolizzo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib58","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2004.11.046","article-title":"Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice","volume":"57","author":"Tremolizzo","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib59","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S1461145712001198","article-title":"Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice","volume":"16","author":"van Enkhuizen","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib60","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.64.8.932","article-title":"Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit\/hyperactivity disorder","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1006\/excr.1999.4691","article-title":"Fate of mesencephalic AHD2-expressing dopamine progenitor cells in NURR1 mutant mice","volume":"253","author":"Wallen","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib62","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/j.1460-9568.2007.05460.x","article-title":"Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells","volume":"25","author":"Wang","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1087057111422378","article-title":"A\u00a0cell-based high-throughput screening assay to measure cellular histone h3 lys27 trimethylation with a modified dissociation-enhanced lanthanide fluorescent immunoassay","volume":"17","author":"Xie","year":"2012","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib64","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1242\/dev.095802","article-title":"Foxa2 acts as a co-activator potentiating expression of the Nurr1-induced DA phenotype via epigenetic regulation","volume":"141","author":"Yi","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib65","first-page":"11","article-title":"Systemic administration of valproic acid and zonisamide promotes differentiation of induced pluripotent stem cell-derived dopaminergic neurons","volume":"7","author":"Yoshikawa","year":"2013","journal-title":"Front. Cell Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.020_bib66","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.276.5310.248","article-title":"Dopamine neuron agenesis in Nurr1-deficient mice","volume":"276","author":"Zetterstrom","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.07.020_bib67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1369-1600.2011.00391.x","article-title":"Ventral midbrain correlation between genetic variation and expression of the dopamine transporter gene in cocaine-abusing versus non-abusing subjects","volume":"19","author":"Zhou","year":"2014","journal-title":"Addict. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T10:24:28Z","timestamp":1659263068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817303519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":68,"alternative-id":["S0028390817303519"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.020","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}